NEW! Pathogenomix granted FDA Breakthrough Device Designation

Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, is announcing that the US Food and Drug Administration (FDA) has granted it a Breakthrough Device Designation for its Patho-Seq assay.

Read more

Infection Intelligence

Ripseq sequence-based analysis reduces the time needed to identify infectious pathogens, in pure- or poly-microbial samples, by up to 90% - and provides answers where other methods fail. Use any sequencing technology you want - Ripseq is platform agnostic.

Combined with Ripseq DB, this is complete SaaS diagnostic solution, able to identify pathogens more accurately, faster and at lower cost than current methods.

Click here for more information.
Free, unlimited use 14-days trial!

Platform agnostic

Ripseq can analyze both NGS & Sanger direct-from-specimen sequencing files. Using our novel algorithms, the total time for one analysis is less than five minutes - no matter if the sample is a pure sample or a poly microbial one.

Curated databases

Our Ripseq DB databases has the most up to date references, but without the clutter. Databases are filtered and automatically curated to ensure an ID you can rely on.

Cloud SaaS solution

Ripseq is always online and always updated. All you need is an internet browser. Our curated reference databases are updated whenever major references are added or changed. 

Ripseq NGS - It is FAST!

Using our novel algorithms Ripseq will process your targeted NGS sequence file locally, and reduce the information needed to upload by a factor of 1000:1, while still retaining resolution and specificity. This means no lengthy file upload, and no costly big data file storage.

After upload, the cloud based Ripseq will analyze the uploaded reads against any of our curated Ripseq DB databases - no matter the target.

All this in less than 5 minutes! Including reporting!

Pathogenomix Ripseq - 5 minute NGS analysis pipeline

Ripseq Sanger - Mono AND polymicrobial samples!

Our Ripseq Sanger products can handle it all. No matter if you have a pure sample, or you have a more complex sample (or InDel) resulting in a mixed chromatogram - Ripseq got your back.

Using our bulk analysis you can save a lot of time on your pure samples - with bulk upload, bulk analysis, automatic confidence status flags (following the CLSI clinical sequencing guidelines) and automatic report generation. No need to sift through hundreds of references in GenBank.

Ripseq can also analyze samples you otherwise would have to discard or at best culture and separate, not knowing if you missed anything.

Pathogenomix Ripseq - Pure and mixed chromatograms - polymicrobial sample analysis from one run

Ripseq DB - The best microbial database there is.

Pathogenomix Pathogenomix Pathogenomix's curated pathogen database Ripseq DB, extends and improves the effectiveness of the public DNA sequence databases such as GenBank and others. While GenBank contains large numbers of current references, it also has many uninformative or even erroneous references that hinder accurate identification. We even cross reference all references with the latest taxonomy from NCBI and update the reference if needed. 

Any target gene or region can be used for identification, ex. 16S, ITS, rpoB and others.

To ensure the best reference quality and accuracy, Ripseq DB enables users to curate a more medically-relevant reference database. Users can annotate, reject and approve references using personalized methods. This on top of the solid foundation of advanced automatic filters and cross referencing makes Ripseq DB the database of choice.

Curated databases are a prerequisite for rapid, accurate analysis of Next Generation Sequencing (NGS) as well as Sanger data. This will ensure that the user can be confident that the analysis results are complete and accurate.

Pathogenomix Ripseq - Our reference database is second to none!